Peracchia A, Bardini R, Asolati M, Ruol A, Bonavina L, Castoro C, Pavanello M
Department of Surgery, University of Padua, Italy.
Hepatogastroenterology. 1991 Dec;38 Suppl 1:72-5.
The ideal surgical treatment for adenocarcinoma of the gastric cardia is still controversial. In 189 consecutive patients who underwent resection, 127 esophagogastric resections and 62 total gastrectomies plus esophageal resection were performed. Short- and long-term results of the two surgical procedures were compared in order to define the specific indications for each. Abdominal nodes were metastatic in 73.5% of the cases, and mediastinal nodes in 29.1% of the patients who were also approached through the thorax. Neoplastic permeation of the esophageal resection margin occurred in 3.2% of the patients. No positive resection margins were found in the cases in whom 10 or more cm. of uninvolved esophagus were resected. The superiority of the laparotomy and right thoracotomy approach was thus evident in terms of oncologic radicality. Anastomotic leakage occurred in 8.7% of esophagogastric resection, and in 6.5% of total gastrectomy plus esophageal resection, patients. No correlation between the stage of the tumor or the neoplastic permeation of the section margin and the incidence of anastomotic leakage was found. Operative mortality was 3.9% after esophagogastric resection, and 6.5% after total gastrectomy plus esophageal resection; this may suggest that esophagogastric resection is the procedure of choice in poor risk and elderly patients. After curative resection, locoregional or systemic neoplastic recurrence was observed in 15.0% of the cases.(ABSTRACT TRUNCATED AT 250 WORDS)
胃贲门腺癌的理想手术治疗方案仍存在争议。在189例接受手术切除的患者中,实施了127例食管胃切除术以及62例全胃切除术加食管切除术。对这两种手术方式的短期和长期结果进行比较,以明确各自的具体适应证。73.5%的病例出现腹部淋巴结转移,在经胸部手术的患者中,29.1%出现纵隔淋巴结转移。3.2%的患者出现食管切缘肿瘤浸润。在切除10厘米或更长无病变食管的病例中,未发现切缘阳性。因此,就肿瘤根治性而言,剖腹术和右胸切开术方法的优势明显。食管胃切除术患者中8.7%发生吻合口漏,全胃切除术加食管切除术患者中6.5%发生吻合口漏。未发现肿瘤分期或切缘肿瘤浸润与吻合口漏发生率之间存在相关性。食管胃切除术后手术死亡率为3.9%,全胃切除术加食管切除术后为6.5%;这可能表明食管胃切除术是风险较高和老年患者的首选术式。根治性切除术后,15.0%的病例出现局部或全身肿瘤复发。(摘要截短至250字)